Page last updated: 2024-08-26

mizoribine and Nephrosis

mizoribine has been researched along with Nephrosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hiromura, K; Kaneko, Y; Kuroiwa, T; Maeshima, A; Nojima, Y; Sakairi, T; Takahashi, S; Takeuchi, S; Tomioka, M1
Gomi, H; Ishimoto, F; Matsuda, H; Sakai, O; Shibasaki, T; Usui, M1

Other Studies

2 other study(ies) available for mizoribine and Nephrosis

ArticleYear
The immunosuppressive drug mizoribine directly prevents podocyte injury in puromycin aminonucleoside nephrosis.
    Nephron. Experimental nephrology, 2010, Volume: 116, Issue:1

    Topics: Animals; Immunosuppressive Agents; IMP Dehydrogenase; Male; Membrane Proteins; Nephrosis; Podocytes; Protein Serine-Threonine Kinases; Puromycin Aminonucleoside; Rats; Rats, Wistar; Ribonucleosides

2010
Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside.
    American journal of nephrology, 1996, Volume: 16, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Immunosuppressive Agents; Male; Nephrosis; Nephrosis, Lipoid; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Ribonucleosides; Thromboxane B2

1996